Publicaciones en las que colabora con SALVADOR FRANCISC ALIÑO PELLICER (19)

2017

  1. Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma

    OncoTargets and Therapy, Vol. 10, pp. 503-514

2012

  1. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics

    PLoS ONE, Vol. 7, Núm. 8

  2. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients

    Expert Opinion on Biological Therapy

2011

  1. Analysis of metabolic and gene expression changes after hydrodynamic DNA injection into mouse liver

    Biological and Pharmaceutical Bulletin, Vol. 34, Núm. 1, pp. 167-172

2010

  1. Naked DNA delivery to whole pig cardiac tissue by coronary sinus retrograde injection employing non-invasive catheterization

    Journal of Gene Medicine, Vol. 12, Núm. 11, pp. 920-926

2007

  1. Pig liver gene therapy by noninvasive interventionist catheterism

    Gene Therapy, Vol. 14, Núm. 4, pp. 334-343

2006

  1. Antigens and cytokine genes in antitumor vaccines: The importance of the temporal delivery sequence in antitumor signals

    Annals of the New York Academy of Sciences

  2. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer

    Annals of the New York Academy of Sciences

2005

  1. Cytokine expression and dendritic cell density in melanoma sentinel nodes

    Melanoma Research, Vol. 15, Núm. 2, pp. 99-106

  2. Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles

    Gene Therapy, Vol. 12, Núm. 11, pp. 927-935

2004

  1. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer

    Colorectal Disease, Vol. 6, Núm. 4, pp. 236-242

2003

  1. Asialofetuin liposomes for receptor-mediated gene transfer into hepatic cells

    Methods in Enzymology, Vol. 373, pp. 399-421

  2. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA

    Gene Therapy, Vol. 10, Núm. 19, pp. 1672-1679

2002

  1. Genoma i salut, aplicacions del genoma en teràpia i salut humana

    Mètode: Revista de difusió de la investigació, Núm. 32, pp. 43-47

  2. Telomerasa: Biología e implicaciones clínicas

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 2, pp. 121-135

2001

  1. Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin

    Cancer Gene Therapy, Vol. 8, Núm. 4, pp. 278-284

  2. Asialofetuin liposome-mediated human α1-antitrypsin gene transfer in vivo results in stationary long-term gene expression

    Journal of Molecular Medicine, Vol. 79, Núm. 4, pp. 205-212

  3. Genoma y salud

    Mètode: Anuario, Núm. 2001, pp. 175-179

  4. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: A simple blood test to monitor disease in cancer patients

    Laboratory Investigation, Vol. 81, Núm. 5, pp. 767-769